The impact of COVID-19 on cancer care of outpatients with low socioeconomic status.
COVID-19
ambulatory care
healthcare disparities
social class
socioeconomic factors
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
01 07 2022
01 07 2022
Historique:
revised:
22
01
2022
received:
02
12
2021
accepted:
27
01
2022
pubmed:
8
2
2022
medline:
18
5
2022
entrez:
7
2
2022
Statut:
ppublish
Résumé
Patients with low socioeconomic status (SES) are among the most underserved groups of people regarding cancer care. Analyzing the impact of the coronavirus-induced disease 2019 (COVID-19) pandemic on health care disparities and calling attention to inequalities in cancer care is crucial to justify and initiate adequate countermeasures. We aimed to determine whether the COVID-19 pandemic aggravated health care disparities of cancer outpatients related to their SES and analyzed patient data of the largest university center providing services for patients with hematologic and oncologic disorders in Austria from 2018 to 2021. SES was assessed using three indicators: monthly net household income, level of education and occupational prestige. In total, 1217 cancer outpatients (51.1% female) with a mean age of 59.4 years (SD = 14.2) participated. In the first year of the pandemic, the relative proportion of individuals with low income, low education level and low occupational prestige seeking cancer care at our outpatient center decreased significantly (P ≤ .015). The strongest indicator was income, with a consistent effect throughout the first pandemic year. Countermeasures and specific interventions to support cancer patients with low SES in their access to health care should be initiated and prioritized.
Identifiants
pubmed: 35128650
doi: 10.1002/ijc.33960
pmc: PMC9087749
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
77-82Informations de copyright
© 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Références
Epidemiol Rev. 2011;33:135-47
pubmed: 21586673
Perspect Public Health. 2021 May;141(3):158-176
pubmed: 32449467
JAMA Otolaryngol Head Neck Surg. 2021 Feb 1;147(2):209-211
pubmed: 33151289
JCO Glob Oncol. 2020 Jun;6:906-912
pubmed: 32589462
Oncologist. 2021 Feb;26(2):e338-e341
pubmed: 33111460
Cancer Med. 2021 Dec;10(24):8854-8865
pubmed: 34845860
J Surg Oncol. 2020 Sep;122(3):371-372
pubmed: 32452031
JAMA Oncol. 2020 Oct 1;6(10):1531-1532
pubmed: 32789508
JAMA Netw Open. 2021 May 3;4(5):e2110946
pubmed: 34028552
J Epidemiol Community Health. 2001 Oct;55(10):693-700
pubmed: 11553651
Int J Cancer. 2022 Jul 1;151(1):77-82
pubmed: 35128650
Int J Cancer. 2022 Apr 15;150(8):1244-1254
pubmed: 34843106
Health Expect. 2022 Apr;25(2):506-512
pubmed: 33974721
Lancet Oncol. 2020 Aug;21(8):1023-1034
pubmed: 32702310